Accession Number: | 0000899243-22-021331 |
Date: | 2022-06-06 |
Issuer: | MERRIMACK PHARMACEUTICALS INC (MACK) |
Original Submission Date: |
NIELSEN ULRIK B.
C/O MERRIMACK PHARMACEUTICALS, INC.
ONE BROADWAY 14TH FLOOR
CAMBRIDGE, MA 02142
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 5.2 | 2022-06-06 | deemed execution date | A | 7,000 (a) | 2032-06-05 | common stock 7,000 | $5.20 | 21,000 | direct |
ID | footnote |
---|---|
f1 | this option vests as to 1/4th of the total number of shares on 7/1/22 and an additional 1/4th of the total number of shares at the end of each successive three month period thereafter until 4/1/23. |